A SYSTEMATIC LITERATURE REVIEW AND INDIRECT COMPARISON OF IRON ISOMALTOSIDE AND FERRIC CARBOXYMALTOSE IN IRON DEFICIENCY ANAEMIA AFTER FAILURE OR INTOLERANCE OF ORAL IRON TREATMENT

被引：0
|
作者：
Pollock, R. [1 ]
Muduma, G. [2 ]
机构：
[1] Covalence Res Ltd, London, England
[2] Pharmacosmos AS, Holbaek, Denmark
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.1829
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY4
引用
收藏
页码：S374 / S374
页数：1
相关论文
共 50 条
  • [31] Ferric carboxymaltose for the treatment of iron-deficiency anemia
    Munoz, Manuel
    Martin-Montanez, Elisa
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (06) : 907 - 921
  • [32] Ferric carboxymaltose - a promising molecule in the treatment of iron deficiency in patients with heart failure
    Bakosova, Maria
    Krejci, Jan
    Spinarova, Lenka
    COR ET VASA, 2021, 63 (06) : 737 - 740
  • [33] Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia Two Randomized Clinical Trials
    Wolf, Myles
    Rubin, Janet
    Achebe, Maureen
    Econs, Michael J.
    Peacock, Munro
    Imel, Erik A.
    Thomsen, Lars L.
    Carpenter, Thomas O.
    Weber, Thomas
    Brandenburg, Vincent
    Zoller, Heinz
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (05): : 432 - 443
  • [34] Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency.
    Anker, Stefan D.
    Comin Colet, Josep
    Filippatos, Gerasimos
    Willenheimer, Ronnie
    Dickstein, Kenneth
    Drexler, Helmut
    Luescher, Thomas F.
    Bart, Boris
    Banasiak, Waldemar
    Niegowska, Joanna
    Kirwan, Bridget-Anne
    Mori, Claudio
    Rothe, Barbara von Eisenhart
    Pocock, Stuart J.
    Poole-Wilson, Philip A.
    Ponikowski, Piotr
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25): : 2436 - 2448
  • [35] Ferric carboxymaltose for treatment of iron deficiency and iron deficiency anemia caused by abnormal uterine bleeding
    Hagras, Ahmed M.
    Hussein, Naglaa Ali
    Abdelazim, Ibrahim
    Elhamamy, Nareman
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2022, 21 (04): : 223 - 228
  • [36] TREATMENT OF IRON DEFICIENCY ANAEMIA OF LATE PREGNANCY WITH A SINGLE INTRAVENOUS IRON POLYMALTOSE OR FERRIC CARBOXYMALTOSE VERSUS ORAL IRON SULPHATE: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY (TIDAL)
    Khalafallah, A.
    Chuang, A.
    Kwok, C.
    Yan, C.
    Hyppa, A.
    Mathew, R.
    Gares, V.
    Dennis, A.
    Falloon, P.
    Gebski, V.
    Pavlov, T.
    HAEMATOLOGICA, 2015, 100 : 131 - 131
  • [37] TREATMENT OF IRON DEFICIENCY ANAEMIA OF LATE PREGNANCY WITH A SINGLE INTRAVENOUS IRON POLYMALTOSE OR FERRIC CARBOXYMALTOSE VERSUS ORAL IRON SULPHATE: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY (TIDAL)
    Khalafallah, A.
    Chuang, A.
    Kwok, C.
    Yan, C.
    Hyppa, A.
    Mathew, R.
    Dennis, A.
    Seaton, D.
    Brain, T.
    Pavlov, T.
    HAEMATOLOGICA, 2014, 99 : 793 - 793
  • [38] IV Ferric Carboxymaltose (Injectafer) for Iron Deficiency in Heart Failure
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2024, 66 (1695): : 22 - 24
  • [39] Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose or oral iron as preoperative treatment in patients with colon cancer and iron deficiency anaemia
    Calvet, Xavier
    Gene, Emili
    AngelRuiz, Miquel
    Figuerola, Ariadna
    Villoria, Albert
    Cucala, Mercedes
    Mearin, Fermin
    Delgado, Salvadora
    Luis Calleja, Jose
    TECHNOLOGY AND HEALTH CARE, 2016, 24 (01) : 111 - 120
  • [40] A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom
    Pollock, Richard F.
    Muduma, Gorden
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (07) : 751 - 759
12345